Opinion Paper: Why Should Governments Invest in Antibiotic Drug Discovery Against Multi-Drug-Resistant Bacteria?

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 9, Iss. 2, 2014-08 ,pp. : 150-150

Bentham Science Publishers

Access to resources Recommend Favorite

Drugs from Natural Substances: Why Study Them in Cerebral Infarction

By  

Cerebrovascular Diseases, Vol. 35, Iss. 1, 2013-03 ,pp. : IV-VI

Karger

Access to resources Recommend Favorite

Letting Them Die: How HIV/AIDS Prevention Programmes Often Fail Catherine Campbell

By Marrengane CN  

African Journal of AIDS Research, Vol. 3, Iss. 1, 2004-05 ,pp. : 101-101

Routledge Ltd

Access to resources Recommend Favorite

Patients with Prehypertension – Do we have Enough Evidence to Treat them?

By  

Current Vascular Pharmacology, Vol. 12, Iss. 4, 2014-07 ,pp. : 586-597

Bentham Science Publishers

Access to resources Recommend Favorite

Workplace programmes for HIV and tuberculosis: A systematic review to support development of international guidelines for the health workforce

By Yassi Annalee   O'Hara Lyndsay M.   Lockhart Karen   Spiegel Jerry M.  

AIDS Care, Vol. 25, Iss. 5, 2013-05 ,pp. : 525-543

Routledge Ltd

Access to resources Recommend Favorite